Target intelligence / Profile preview

Gut microbiome

Molecular classification
Other
01

Overview

The term "gut microbiome restoration" does not refer to a specific molecule or receptor but rather describes therapeutic strategies aimed at re-establishing a healthy balance and diversity within the gut microbial community. The gut microbiome is an ecosystem composed primarily of bacteria but also includes viruses, fungi, archaea and other microorganisms that inhabit the gastrointestinal tract. These microbes play essential roles in digestion; synthesis of vitamins; production of short-chain fatty acids; metabolism; maintenance of the intestinal barrier; modulation of immune responses; and protection against pathogens. Disruption to this ecosystem—through antibiotics use, illness or other factors—can lead to dysbiosis associated with various diseases including recurrent Clostridioides difficile infection (*C. diff*), inflammatory conditions and even neurodegenerative disorders. Restoration approaches include fecal microbiota transplantation (FMT), administration of defined microbial consortia such as SER‑109 or RBX2660 capsules/enemas derived from healthy donors’ stool samples as well as dietary interventions using prebiotic fibers. While these therapies have shown efficacy in treating recurrent *C. diff* infections by restoring microbial diversity that suppresses pathogen overgrowth,[1][3][5] they are not molecular targets themselves but rather broad ecological interventions. Safety concerns include risk for transmission of infectious agents from donor material,[1][3] lack standardization across products,[3] variable efficacy depending on patient population/study design,[3] and incomplete understanding regarding long-term effects. Because "gut microbiome restoration" is not a single molecule/receptor/target classifiable under conventional pharmacological categories like "receptor," "enzyme," etc., it should be considered an incorrect entry if used as a drug target name.[2][4]

Other names
Gut floraIntestinal microbiotaGastrointestinal microbiomeMicrobiota
02

Mechanism of action

Restoration or modulation of microbial diversity to outcompete pathogenic bacteria and restore metabolic/immune homeostasis[1][3][5]

03

Biological functions

Digestion and metabolism of nutrientsSynthesis of vitamins (e.g., B1, B9, B12, K)Production of short-chain fatty acidsModulation of immune responseMaintenance of gut barrier integrityMetabolism of bile acids[7][8]
04

Disease associations

Infection (notably Clostridioides difficile infection)Inflammation (including autoimmune diseases)Metabolic disordersNeurodegenerative disease (e.g., Parkinson’s disease)[4]Other
05

Safety considerations

Transmission of infectious agents via donor-derived therapies such as FMT or MRTs[1][3][5]Lack of product standardization and regulatory oversight for some interventions[3]Potential for adverse immune reactions or dysbiosis with inappropriate use
06

Interacting drugs

Fecal microbiota transplantation products (e.g., SER‑109, RBX2660)[5]

2 more in the full profile.

07

Biomarkers

Short-chain fatty acid levels (acetate, propionate, butyrate)Relative abundance/diversity indices for key bacterial genera/speciesTryptophan metabolites (indole derivatives)Modified bile acids[8]

Beyond the preview

Go deeper on Gut microbiome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call